Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 USD | -3.21% | -5.07% | +17.71% |
May. 15 | Transcript : Plus Therapeutics, Inc., Q1 2024 Earnings Call, May 15, 2024 | |
May. 09 | Transcript : Plus Therapeutics, Inc. - Special Call |
Evolution of the average Target Price on Plus Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Plus Therapeutics, Inc.
HC Wainwright | |
Maxim | |
JonesTrading Institutional Services | |
Ladenburg Thalmann |
EPS Revisions
- Stock Market
- Equities
- PSTV Stock
- Consensus Plus Therapeutics, Inc.